Chagas Disease Diagnostic Testing in Two Academic Hospitals in New Orleans, Louisiana: A Call to Action

Chagas disease, caused by the protozoa parasite Trypanosoma cruzi, is an anthropozoonosis that represents a major public health problem in the Americas, affecting 7 million people with at least 65 million at risk. We sought to assess the intensity of disease surveillance based on diagnostic test requests from hospitals in New Orleans, Louisiana. We extracted information from send-out labs at two major tertiary academic hospitals in New Orleans, Louisiana, USA, from 1 January 2018 to 1 December 2020. We found that in these three years there were 27 patients for whom Chagas disease testing was ordered. Most of these patients were male (70%), with a median age of 40 years old, and their most common ethnical background was Hispanic (74%). These findings demonstrate undertesting of this neglected disease in our region. Given the low Chagas disease surveillance, we need to increase awareness, health promotion, and education among healthcare workers.

[1]  Jeremy R. Wang,et al.  Amplicon sequencing reveals complex infection in infants congenitally infected with Trypanosoma cruzi and informs the dynamics of parasite transmission , 2022, bioRxiv.

[2]  R. Marcus,et al.  Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States , 2022, Emerging infectious diseases.

[3]  C. Milliren,et al.  Effect of clinician information sessions on diagnostic testing for Chagas disease , 2022, PLoS Neglected Tropical Diseases.

[4]  D. Hamer,et al.  Recommendations for Screening and Diagnosis of Chagas Disease in the United States , 2021, The Journal of infectious diseases.

[5]  L. Mestroni,et al.  Experiences with Diagnosis and Treatment of Chagas Disease at a United States Teaching Hospital—Clinical Features of Patients with Positive Screening Serologic Testing , 2021, Tropical medicine and infectious disease.

[6]  J. Köhler,et al.  Perceived barriers to Chagas disease screening among a diverse group of prenatal care providers , 2021, PloS one.

[7]  Sassan Noazin,et al.  Risk factors for vertical transmission of Chagas disease: A systematic review and meta-analysis , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  R. Marcus,et al.  Recognition and screening for Chagas disease in the USA , 2021, Therapeutic advances in infectious disease.

[9]  Bruno M. Ghersi,et al.  In the heart of the city: Trypanosoma cruzi infection prevalence in rodents across New Orleans , 2020, Parasites & Vectors.

[10]  Claudia P Herrera,et al.  Raccoons As an Important Reservoir for Trypanosoma cruzi: A Prevalence Study from Two Metropolitan Areas in Louisiana. , 2020, Vector borne and zoonotic diseases.

[11]  Brian H. Bossak,et al.  Contemporary Autochthonous Human Chagas Disease in the USA. , 2020, Acta tropica.

[12]  I. Camelo,et al.  Simple and effective screening for Chagas disease at the prenatal intake visit , 2019 .

[13]  L. Messenger,et al.  Chagas Disease in the United States: a Public Health Approach , 2019, Clinical Microbiology Reviews.

[14]  J. Altcheh,et al.  Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women , 2019, PLoS neglected tropical diseases.

[15]  S. Meymandi,et al.  Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States , 2019, PLoS neglected tropical diseases.

[16]  L. Bavia,et al.  Chagas Disease: From Discovery to a Worldwide Health Problem , 2019, Front. Public Health.

[17]  C. Morillo,et al.  Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management A Scientific Statement From the American Heart Association , 2018, Circulation.

[18]  S. Montgomery,et al.  Chagas Disease Surveillance Activities — Seven States, 2017 , 2018, MMWR. Morbidity and mortality weekly report.

[19]  S. Montgomery,et al.  Congenital Chagas Disease in the United States: Cost Savings through Maternal Screening , 2018, The American journal of tropical medicine and hygiene.

[20]  S. Montgomery,et al.  Survey of Pediatric Infectious Diseases Society Members About Congenital Chagas Disease , 2017, The Pediatric infectious disease journal.

[21]  S. Montgomery,et al.  Diagnosis and Treatment of Congenital Chagas Disease in a Premature Infant. , 2016, Journal of the Pediatric Infectious Diseases Society.

[22]  S. Montgomery,et al.  Estimating the Burden of Chagas Disease in the United States , 2016, PLoS neglected tropical diseases.

[23]  S. Tiwari,et al.  Chagas Cardiomyopathy in New Orleans and the Southeastern United States. , 2016, The Ochsner journal.

[24]  J. Urbina,et al.  Congenital Chagas’ disease transmission in the United States: Diagnosis in adulthood , 2016, IDCases.

[25]  P. Hotez,et al.  Historical Perspectives on the Epidemiology of Human Chagas Disease in Texas and Recommendations for Enhanced Understanding of Clinical Chagas Disease in the Southern United States , 2015, PLoS neglected tropical diseases.

[26]  P. Buekens,et al.  Congenital Chagas disease: an update , 2015, Memorias do Instituto Oswaldo Cruz.

[27]  S. Montgomery,et al.  Perinatal Screening for Chagas Disease in Southern Texas. , 2015, Journal of the Pediatric Infectious Diseases Society.

[28]  P. Hotez,et al.  Global economic burden of Chagas disease: a computational simulation model. , 2013, The Lancet. Infectious diseases.

[29]  M. Py Neurologic Manifestations of Chagas Disease , 2011, Current neurology and neuroscience reports.

[30]  S. Montgomery,et al.  Survey of obstetrician-gynecologists in the United States about Chagas disease. , 2010, The American journal of tropical medicine and hygiene.

[31]  N. M. Matsuda,et al.  The Chronic Gastrointestinal Manifestations of Chagas Disease , 2009, Clinics.

[32]  S. Montgomery,et al.  An estimate of the burden of Chagas disease in the United States. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  S. Montgomery,et al.  Chagas disease and the US blood supply , 2008, Current opinion in infectious diseases.

[34]  P. Dorn,et al.  Autochthonous Transmission of Trypanosoma cruzi, Louisiana , 2007, Emerging infectious diseases.

[35]  L. Hwang,et al.  Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Daryl Inniss,et al.  Data Center , 2022, Encyclopedia of Big Data.

[37]  Chagas disease in Latin America: an epidemiological update based on 2010 estimates. , 2015, Releve epidemiologique hebdomadaire.

[38]  P. Dorn,et al.  Triatoma sanguisuga blood meals and potential for Chagas disease, Louisiana, USA. , 2014, Emerging infectious diseases.

[39]  K. Kurkjian,et al.  Congenital transmission of Chagas disease - Virginia, 2010. , 2012, MMWR. Morbidity and mortality weekly report.